Pro-Life Group Welcomes FDA Review of Abortion Pill Mifepristone

National Right to Life today welcomed the Food and Drug Administration’s announcement that it is moving forward with a comprehensive review of the abortion drug mifepristone and its safety record. According to multiple news reports, the FDA is conducting a large-scale analysis of hundreds of thousands of cases and will examine data related to adverse events and complications associated with the drug.The following is a statement from Carol Tobias, president of National Right to Life:For yea